Atlas Trials

Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa

Clinical trial NCT01715922 · UNKNOWN

Trial details

NCT number
NCT01715922
Sponsor
ANRS, Emerging Infectious Diseases
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cryptococcal MeningitisHIV
Start date
2012-05-01
Primary completion
2015-09-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.